dc.contributor.author |
Forschner, Andrea Lydia |
|
dc.date.accessioned |
2024-06-18T08:12:45Z |
|
dc.date.available |
2024-06-18T08:12:45Z |
|
dc.date.issued |
2023 |
|
dc.identifier.issn |
0959-8049 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/154299 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Oxford : Elsevier Sci Ltd |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1016/j.ejca.2023.112986 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Practical guidelines for the management of adverse events of the T cell engager bispecific tebentafusp |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20240124000000_01590 |
|
utue.personen.roh |
Hassel, Jessica C. |
|
utue.personen.roh |
Berking, Carola |
|
utue.personen.roh |
Forschner, Andrea |
|
utue.personen.roh |
Gebhardt, Christoffer |
|
utue.personen.roh |
Heinzerling, Lucie |
|
utue.personen.roh |
Meier, Friedegund |
|
utue.personen.roh |
Ochsenreither, Sebastian |
|
utue.personen.roh |
Siveke, Jens |
|
utue.personen.roh |
Hauschild, Axel |
|
utue.personen.roh |
Schadendorf, Dirk |
|
dcterms.isPartOf.ZSTitelID |
European Journal of Cancer |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article 112986 |
de_DE |
dcterms.isPartOf.ZS-Volume |
191 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |